Surrozen, Inc./DE — Director's Dealing 2020

Nov 19, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Consonance-HFW Acquisition Corp. (CHFW)
CIK: 0001824893
Period of Report: 2020-11-18

Reporting Person: Livingston Kevin Harold (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Ordinary Shares	$		Class A Ordinary Shares (2300000)		Indirect

Footnotes

F1: The shares will automatically convert into Class A ordinary Shares at the time of the Issuer's initial business combination.

F2: This number includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise in full their over-allotment as described in the Issuer's registration statement.

F3: These shares are directly held by Consonance Life Sciences. This entity is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such they have voting and investment discretion with respect to these shares and may be deemed to share beneficial ownership of these shares. The Reporting Person disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.